The Hsp90 inhibitor SNX-2112 also induced PARP cleavage as well as the reduction in GRP78 expression in the multidrug-resistant human chronic myeloid leukemia K562/ADR cell line (27). This evidence concerns the gene HSPA5 and chronic myelogenous leukemia, BCR-ABL1 positive.